Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,543,897
+$90,449 QoQ
Shares Held
13,954
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#1,876
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. JNJ ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,522 | $3,026,317 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,543,897 | 13,954 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,453,448 | 14,128 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,956,694 | 14,287 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,676,537 | 14,435 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,219,610 | 14,531 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,415,127 | 14,563 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,034,080 | 14,065 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,295,417 | 14,164 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,995,376 | 13,652 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,222,569 | 14,050 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,280,410 | 14,549 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,281,426 | 14,648 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,440,757 | 14,746 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,287,645 | 14,759 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,678,897 | 15,165 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,510,516 | 15,368 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,749,984 | 15,492 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,770,813 | 15,634 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,808,456 | 16,417 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,570,434 | 15,916 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,588,889 | 15,715 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,585,061 | 15,729 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,461,108 | 15,638 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,328,036 | 15,637 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,207,328 | 15,696 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,058,085 | 15,695 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||